Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis

Neuroendocrinology

Volumn 97, Issue 4, 2013, Pages 300-308

  Kimura, Ryosuke ^a   Okouchi, Masahiro ^b   Kato, Takashi ^a   Imaeda, Kenro ^a   Okayama, Naotsuka ^a   Asai, Kiyofumi ^a   Joh, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Bisai Hospital   (Japan)

Author keywords

Apoptosis; EGF transactivation; G protein coupled receptor; Glucagon like peptide 1; Methylglyoxal; PC12 cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCAGON LIKE PEPTIDE 1; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; NONHUMAN; PC12 CELL LINE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

EID: 84879148073     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000345529     Document Type: Article

References (54)

1. Ristow M: Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 2004; 82: 510-529.
2. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, et al: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45: 1161-1168.
3. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999; 53: 1937-1942.
4. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA: Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61: 661-666.
5. Kimura R, Tomiyasu H, Takeuchi T, Shimizu M, Hayashi Y, Okayama N, Kamiya Y, Joh T: Prevalence of Alzheimer's disease with diabetes in the Japanese population. Psychogeriatrics 2008; 8: 73-78.
6. Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH: Glucagonlike peptide-1 decreases endogenous amyloid-peptide (A levels and protects hippocampal neurons from death induced by A and iron. J Neurosci Res 2003; 72: 603-612.
7. Perry T, Greig NH: Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease. Curr Alzheimer Res 2005; 2: 377-385.
8. Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Ronnholm H, Wikstrom L: Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease. J Neurosci Res 2008; 86: 326-338.
9. Damholt AB, Kofod H, Buchan AM: Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell Tissue Res 1999; 298: 287-293.
10. Andreev J, Galisteo ML, Kranenburg O, Logan SK, Chiu ES, Okigaki M, Cary LA, Moolenaar WH, Schlessinger J: Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor but are not required for coupling to the mitogen-Activated protein kinase signaling cascade. J Biol Chem 2001; 276: 20130-20135.
11. Mortensen K, Christensen LL, Holst JJ, Orskov C: GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 2003; 114: 189-196.
12. Kastin AJ, Akerstrom V, Pan W: Interactions of glucagon-like peptide-1 with the bloodbrain barrier. J Mol Neurosci 2002; 18: 7-14.
13. Campos RV, Lee YC, Drucker DJ: Divergent tissue-specific and developmental expression of receptors for glucagon and glucagonlike peptide-1 in the mouse. Endocrinology 1994; 134: 2156-2164.
14. Calvo JC, Yusta B, Mora F, Blazquez E: Structural characterization by affinity cross-linking of glucagon-like peptide-1 (7-36) amide receptor in rat brain. J Neurochem 1995; 64: 299-306.
15. Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP: Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 1995; 7: 2294-2300.
16. Liu J, Yin F, Zheng X, Jing J, Hu Y: Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem Int 2007; 51: 361-369.
17. Qin Z, Sun Z, Huang J, Hu Y, Wu Z, Mei B: Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-peptide (1-42). Neurosci Lett 2008; 444: 217-221.
18. Kimura R, Okouchi M, Fujioka H, Ichiyanagi A, Ryuge F, Mizuno T, Imaeda K, Okayama N, Kamiya Y, Asai K, Joh T: Glucagon-like peptide-1 protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience 2009; 162: 1212-1219.
19. Holbro T, Hynes NE: ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 2004; 44: 195-217.
20. Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996; 379: 557-560.
21. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A: Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 2001; 20: 1594-1600.
22. Brubaker PL, Drucker DJ: Structure-function of the glucagon receptor family of Gprotein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 2002; 8: 179-188.
23. Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinhofer I, Maly K, Ullrich A: Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem 1997; 272: 24767-24770.
24. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-Activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 1998; 273: 8890-8896.
25. Tsai W, Morielli AD, Peralta EG: The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J 1997; 16: 4597-4605.
26. Frank GD, Eguchi S: Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II. Antioxid Redox Signal 2003; 5: 771-780.
27. Frank GD, Mifune M, Inagami T, Ohba M, Sasaki T, Higashiyama S, Dempsey PJ, Eguchi S: Distinct mechanisms of receptor and non-receptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-. Mol Cell Biol 2003; 23: 1581-1589.
28. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ: G subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G-protein-coupled receptor-mediated Ras activation. J Biol Chem 1997; 272: 4637-4644.
29. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402: 884-888.
30. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T: Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 2001; 276: 7957-7962.
31. Dempsey PJ, Garton K, Raines EW: Emerging roles of TACE as a key protease in ErbB ligand shedding. Mol Interv 2002; 2: 136-141.
32. Huovila AP, Turner AJ, Pelto-Huikko M, Karkkainen I, Ortiz RM: Shedding light on ADAM metalloproteinases. Trends Biochem Sci 2005; 30: 413-422.
33. Wang X, Martindale JL, Liu Y, Holbrook NJ: The cellular response to oxidative stress: influences of mitogen-Activated protein kinase signalling pathways on cell survival. Biochem J 1998; 333: 291-300.
34. Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962; 237: 1555-1562.
35. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936-939.
36. Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ: Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989; 243: 1074-1076.
37. Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV: Human transforming growth factor-: precursor structure and expression in E. coli . Cell 1984; 38: 287-297.
38. Shing Y, Christofori G, Hanahan D, Ono Y, Sasada R, Igarashi K, Folkman J: Betacellulin: a mitogen from pancreatic cell tumors. Science 1993; 259: 1604-1607.
39. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, Okuyama T, Hanada K: Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 1995; 270: 7495-7500.
40. Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD, Kumble KD: Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem 2001; 276: 18265-18271.
41. Hackel PO, Zwick E, Prenzel N, Ullrich A: Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 1999; 11: 184-189.
42. Moghal N, Sternberg PW: Multiple positive and negative regulators of signaling by the EGF-receptor. Curr Opin Cell Biol 1999; 11: 190-196.
43. Shelton JG, Steelman LS, Abrams SL, White ER, Akula SM, Franklin RA, Bertrand FE, McMahon M, McCubrey JA: Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines. Cell Cycle 2005; 4: 822-830.
44. Cao C, Lu S, Jiang Q, Wang WJ, Song X, Kivlin R, Wallin B, Bagdasarian A, Tamakloe T, Chu WM, Marshall J, Kouttab N, Xu A, Wan Y: EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells. Cell Signal 2008; 20: 1830-1838.
45. Buteau J, Foisy S, Joly E, Prentki M: Glucagon-like peptide 1 induces pancreatic cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 2003; 52: 124-132.
46. Satoh T, Enokido Y, Kubo T, Yamada M, Hatanaka H: Oxygen toxicity induces apoptosis in neuronal cells. Cell Mol Neurobiol 1998; 18: 649-666.
47. Peng H, Wen TC, Tanaka J, Maeda N, Matsuda S, Desaki J, Sudo S, Zhang B, Sakanaka M: Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia-And free radical-induced injuries. J Cereb Blood Flow Metab 1998; 18: 349-360.
48. Piiper A, Dikic I, Lutz MP, Leser J, Kronenberger B, Elez R, Cramer H, Muller-Esterl W, Zeuzem S: Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J Biol Chem 2002; 277: 43623-43630.
49. Ohtsu H, Dempsey PJ, Eguchi S: ADAMs as mediators of EGF receptor transactivation by G-protein-coupled receptors. Am J Physiol Cell Physiol 2006; 291:C1-C10.
50. Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, Tsuzuki H, Maekawa R, Yoshioka T, Kawada K, Sugita K, Ohtani M: Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J Med Chem 1998; 41: 640-649.
51. Saito S, Frank GD, Motley ED, Dempsey PJ, Utsunomiya H, Inagami T, Eguchi S: Metalloprotease inhibitor blocks angiotensin IIinduced migration through inhibition of epidermal growth factor receptor transactivation. Biochem Biophys Res Commun 2002; 294: 1023-1029.
52. Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP: Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem 1999; 274: 3531-3540.
53. Zhou Y, Besner GE: Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells. Neurosignals 2010; 18: 141-151.
54. Miettinen P, Ormio P, Hakonen E, Banerjee M, Otonkoski T: EGF receptor in pancreatic cell mass regulation. Biochem Soc Trans 2008; 36: 280-285.